The global liquid biopsy market size was valued at USD 7.05 billion in 2022 and is expected to grow at a CAGR of 14.4% during the forecast period. By using a blood sample as a non-invasive substitute for surgical biopsies, liquid biopsy enables medical professionals to learn more about a tumor and tailor the treatment accordingly.

Read More: https://wemarketresearch.com/r....eports/liquid-biopsy